Sandoz Group AG (SDZ.SW)

Swiss · Healthcare · Drug Manufacturers - Specialty & Generic
80.50 CHF-0.91%As of 2026-11-22 · CHF
Last session low 80.06 CHFLast session high 81.28 CHF
52-week low 54.46 CHF52-week high 86.90 CHF
Market cap (USD)
$41.49B
Sector
Healthcare
P/E (TTM)
68.8x
Dividend yield
0.99%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in CHF.

IndicatorValueReading
RSI (14)49.6In the neutral range (30 to 70)
MACD (12, 26, 9)1.61Below its signal line (2.43); histogram -0.81
Bollinger %B (20, 2)9%Inside the bands (79.89 to 86.44)
SMA 2083.16Price is 3.2% below
SMA 5076.25Price is 5.6% above
SMA 20068.85Price is 16.9% above
ATR (20)2.63% of priceAverage true range per day
52-week position80%In the upper part of the 54.46 to 86.90 range

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology.

Latest fiscal yearEnded 2025-12-31: revenue of $11.16B and an operating margin of 12.8%.

More in Drug Manufacturers - Specialty & Generic